Cencora Announces Q3 Fiscal 2024 Earnings Release Date and Conference Call
Cencora, Inc. (NYSE: COR) has announced plans to release its Third Quarter Fiscal 2024 results on Wednesday, July 31, 2024, before the New York Stock Exchange opens for trading. The company will host a conference call at 8:30 a.m. ET on the same day to discuss the results.
The conference call will feature:
- Steven H. Collis, Chairman, President & Chief Executive Officer
- James F. Cleary, Executive Vice President & Chief Financial Officer
- Robert P. Mauch, Executive Vice President & Chief Operating Officer
The live call will be webcast on the company’s website at investor.cencora.com. Participants are encouraged to log on approximately 10 minutes before the call begins.
To join the call via telephone:
- From the United States and Canada: dial (833) 470-1428
- From outside the United States and Canada: dial +1 (404) 975-4839
- Access code: 393872
Replays of the call will be available via telephone and webcast about an hour after the call concludes. The webcast replay will be accessible on investor.cencora.com for one year. The telephone replay will be available for seven days:
- From the United States and Canada: dial (866) 813-9403
- From outside the United States: dial +1 (929) 458-6194
- Access code: 371683
For updates on the webcast timing and replay information, visit investor.cencora.com.
Cencora is a leading global pharmaceutical solutions organization dedicated to improving the lives of people and animals worldwide. Partnering with pharmaceutical innovators across the value chain, Cencora facilitates and optimizes market access to therapies. Healthcare providers rely on Cencora for the secure and reliable delivery of pharmaceuticals, healthcare products, and solutions. With over 46,000 team members globally, Cencora is committed to creating healthier futures. The company ranks #10 on the Fortune 500 and #24 on the Global Fortune 500, generating more than $250 billion in annual revenue. Learn more at investor.cencora.com.
